Allosteric inhibition of aminopeptidase N functions related to tumor growth and virus infection

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Santiago, César ^a   Mudgal, Gaurav ^a,b   Reguera, Juan ^a,c   Recacha, Rosario ^a,d   Albrecht, Sébastien ^e   Enjuanes, Luis ^a   Casasnovas, José M ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b MANGALAYATAN UNIVERSITY   (India)

^c INSERM   (France)

^d LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

^e UNIVERSITÉ DE HAUTE ALSACE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DISULFIDE; MICROSOMAL AMINOPEPTIDASE;

ALLOSTERISM; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOCATALYSIS; CELL PROLIFERATION; CHEMISTRY; CHO CELL LINE; CORONAVIRINAE; CORONAVIRUS INFECTION; CRICETULUS; DRUG EFFECT; ENZYME ACTIVE SITE; HAMSTER; HUMAN; METABOLISM; MOLECULAR MODEL; NEOPLASM; PATHOLOGY; PHYSIOLOGY; PIG; PROTEIN DOMAIN; VIROLOGY;

ALLOSTERIC REGULATION; ANIMALS; ANTINEOPLASTIC AGENTS; BIOCATALYSIS; CATALYTIC DOMAIN; CD13 ANTIGENS; CELL PROLIFERATION; CHO CELLS; CORONAVIRUS; CORONAVIRUS INFECTIONS; CRICETINAE; CRICETULUS; DISULFIDES; HUMANS; MODELS, MOLECULAR; NEOPLASMS; PROTEIN DOMAINS; SUS SCROFA;

EID: 85017404362     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep46045     Document Type: Article

References (41)

1. Taylor, A. Aminopeptidases: Structure and function. FASEB J. 7, 290-298 (1993).
2. Hooper, N. M. Families of zinc metalloproteases. FEBS Lett. 354, 1-6 (1994).
3. Mina-Osorio, P. The moonlighting enzyme CD13: Old and new functions to target. Trends Mol. Med. 14, 361-371 (2008).
4. Delmas, B., et al. Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV. Nature 357, 417-420 (1992).
5. Yeager, C. L., et al. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 357, 420-422 (1992).
6. Fujii, H., et al. Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13. Clin. Exp. Metastasis 13, 337-344 (1995).
7. Pasqualini, R., et al. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res. 60, 722-727 (2000).
8. Sato, Y. Role of aminopeptidase in angiogenesis. Biol Pharm Bull 27, 772-776 (2004).
9. Danziger, R. S. Aminopeptidase N in arterial hypertension. Heart Fail. Rev. 13, 293-298 (2008).
10. Wickström, M., Larsson, R., Nygren, P., Gullbo, J. Aminopeptidase N (CD13) as a target for cancer chemotherapy. Cancer Science 102, 501-508 (2011).
11. Rangel, R., et al. Impaired angiogenesis in aminopeptidase N-null mice. Proc. Natl. Acad. Sci. USA 104, 4588-4593 (2007).
12. Corti, A., Curnis, F., Arap, W., Pasqualini, R. The neovasculature homing motif NGR: More than meets the eye. Blood 112, 2628-2635 (2008).
13. Inagaki, Y., et al. Novel aminopeptidase N (APN/CD13) inhibitor 24F can suppress invasion of hepatocellular carcinoma cells as well as angiogenesis. Biosci. Trends 4, 56-60 (2010).
14. Masters, P. S. The molecular biology of coronaviruses. Adv. Virus Res. 66, 193-292 (2006).
15. Tusell, S. M., Schittone, S. A., Holmes, K. V. Mutational analysis of aminopeptidase N, a receptor for several group 1 coronaviruses, identifies key determinants of viral host range. J. Virol. 81, 1261-1273 (2007).
16. Reguera, J., et al. Structural Bases of Coronavirus Attachment to Host Aminopeptidase N and Its Inhibition by Neutralizing Antibodies. PLoS Pathog. 8, e1002859, 10. 1371/journal. ppat. 1002859 (2012).
17. Danielsen, E. M. Biosynthesis of intestinal microvillar proteins. Dimerization of aminopeptidase N and lactase-phlorizin hydrolase. Biochemistry 29, 305-308 (1990).
18. Sjostrom, H., Noren, O., Olsen, J. Structure and function of aminopeptidase N. Adv Exp. Med. Biol. 477, 25-34 (2000).
19. Wong, A. H., Zhou, D., Rini, J. M. The X-ray crystal structure of human aminopeptidase N reveals a novel dimer and the basis for peptide processing. J. Biol. Chem. 287, 36804-36813 (2012).
20. Addlagatta, A., Gay, L., Matthews, B. W. Structure of aminopeptidase N from Escherichia coli suggests a compartmentalized, gated active site. Proc. Natl. Acad. Sci. USA 103, 13339-13344 (2006).
21. Chen, L., Lin, Y.-L., Peng, G., Li, F. Structural basis for multifunctional roles of mammalian aminopeptidase N. Proc. Natl. Acad. Sci. USA 109, 17966-17971 (2012).
22. Reguera, J., Mudgal, G., Santiago, C., Casasnovas, J. M. A structural view of coronavirus-receptor interactions. Virus Res. 194, 3-15 (2014).
23. Kyrieleis, O. J. P., Goettig, P., Kiefersauer, R., Huber, R., Brandstetter, H. Crystal Structures of the Tricorn Interacting Factor F3 from Thermoplasma acidophilum, a Zinc Aminopeptidase in Three Different Conformations. J. Mol. Biol. 349, 787-800 (2005).
24. Kochan, G., et al. Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming. Proc. Natl. Acad. Sci. USA 108, 7745-7750 (2011).
25. Xu, Y., Wellner, D., Scheinberg, D. A. Cryptic and regulatory epitopes in CD13/aminopeptidase N. Exp. Hematol. 25, 521-529 (1997).
26. Su, L., et al. Development of Synthetic Aminopeptidase N/CD13 Inhibitors to Overcome Cancer Metastasis and Angiogenesis. ACS. Med. Chem. Lett. 3, 959-964 (2012).
27. Schmitt, C., et al. Selective aminopeptidase-N (CD13) inhibitors with relevance to cancer chemotherapy. Bioorg. Med. Chem. 21, 2135-2144 (2013).
28. Nguyen, T. T., et al. Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1. Nat. Struct. Mol. Biol. 18, 604-613 (2011).
29. Bauvois, B., Dauzonne, D. Aminopeptidase-N/CD13 (EC 3. 4. 11. 2) inhibitors: Chemistry, biological evaluations, and therapeutic prospects. Med. Res. Rev. 26, 88-130 (2006).
30. Maiereanu, C., et al. A novel amino-benzosuberone derivative is a picomolar inhibitor of mammalian aminopeptidase N/CD13. Bioorg. Med. Chem. 19, 5716-5733 (2011).
31. Delmas, B., et al. Determinants essential for the transmissible gastroenteritis virus-receptor interaction reside within a domain of aminopeptidase-N that is distinct from the enzymatic site. J. Virol. 68, 5216-5224 (1994).
32. Revelant, G., et al. Exploring S1 plasticity and probing S1? subsite of mammalian aminopeptidase N/CD13 with highly potent and selective aminobenzosuberone inhibitors. Bioorg. Med. Chem. 23, 3192-3207 (2015).
33. Akita, S., et al. MT95-4, a fully humanized antibody raised against aminopeptidase N, reduces tumor progression in a mouse model. Cancer Sci. 106, 921-928 (2015).
34. Tzeng, S.-R., Kalodimos, C. G. Allosteric inhibition through suppression of transient conformational states. Nat. Chem. Biol. 9, 462-465 (2013).
35. Reguera, J., Ordonõ, D., Santiago, C., Enjuanes, L., Casasnovas, J. M. Antigenic modules in the N-terminal S1 region of the Transmissible Gastroenteritis Virus spike protein. J. Gen. Virol. 92, 1117-1126 (2011).
36. Kabsch, W. X. D. S. Acta Cryst. D66, 125-132 (2010).
37. Collaborative Computational Project, N. The CCP4 Suite: Programs for Protein Crystallography. Acta Cryst. D50, 760-763 (1994).
38. Read, R. J. Pushing the boundaries of molecular replacement with maximum likelihood. Acta Cryst. D57, 1373-1382 (2001).
39. Panjikar, S., Parthasarathy, V., Lamzin, V. S., Weiss, M. S., Tucker, P. A. On the combination of molecular replacement and singlewavelength anomalous diffraction phasing for automated structure determination. Acta Cryst. D65, 1089-1097 (2009).
40. Adams, P. D., et al. PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Cryst. D66, 213-221 (2010).
41. Emsley, P., Cowtan, K. Coot: Model-building tools for molecular graphics. Acta Cryst. D60, 2126-2132 (2004).